The forecast indicates a gradual decline in the re-import of penicillins or streptomycins in dosage forms to the UK from 2024 to 2028, with values decreasing year by year. In 2023, the market stood at a slightly higher value than forecasted for 2024. The year-on-year decreases from 2025 to 2028 are each approximately 2% to 2.5%. The compound annual growth rate (CAGR) over the forecast period shows a decreasing trend of about 2% annually.
Future trends to watch for include regulatory changes affecting pharmaceutical imports, potential fluctuations in demand due to evolving healthcare needs, and shifts in global trade policies that may impact import strategies and costs.
